Antagonism of antiviral and allogeneic activity of a human public ctl clonotype by a single altered peptide ligand: Implications for allograft rejection

Lauren Kate Ely, Kate J Green, Travis Clarke Beddoe, Craig Steven Clements, John J Miles, Stephen Paul Bottomley, Danielle Zernich, Lars Kjer-Nielsen, Anthony W Purcell, James McCluskey, Jamie Rossjohn, S R Burrows

Research output: Contribution to journalArticleResearchpeer-review

26 Citations (Scopus)
Original languageEnglish
Pages (from-to)5593 - 5601
Number of pages9
JournalJournal of Immunology
Volume174
Issue number9
Publication statusPublished - 2005

Cite this

Ely, L. K., Green, K. J., Beddoe, T. C., Clements, C. S., Miles, J. J., Bottomley, S. P., ... Burrows, S. R. (2005). Antagonism of antiviral and allogeneic activity of a human public ctl clonotype by a single altered peptide ligand: Implications for allograft rejection. Journal of Immunology, 174(9), 5593 - 5601.